Evidence map›Paper›PMID 34916549›Full record

ArticleScientific reports2021

Bioengineering the ameloblastoma tumour to study its effect on bone nodule formation.

Deniz Bakkalci, Amrita Jay, Azadeh Rezaei, Christopher A Howard, Håvard Jostein Haugen, Judith Pape, Shosei Kishida, Michiko Kishida, Gavin Jell, Timothy R Arnett and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Deniz BakkalciUCL Centre of 3D Models Health and Disease, Division of Surgery and Interventional Sciences, University College London, Charles Bell House, London, UK.
Amrita JayUniversity College London Hospitals, London, UK.
Azadeh RezaeiDivision of Surgery and Interventional Sciences, University College London, Royal Free Campus, London, UK.
Christopher A HowardDeparment of Physics & Astronomy, University College London, London, UK.
Håvard Jostein HaugenDepartment of Biomaterial Institute for Clinical Dentistry, University of Oslo, Oslo, Norway.
Judith PapeUCL Centre of 3D Models Health and Disease, Division of Surgery and Interventional Sciences, University College London, Charles Bell House, London, UK.
Shosei KishidaDepartment of Biochemistry and Genetics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Michiko KishidaDepartment of Biochemistry and Genetics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Gavin JellDivision of Surgery and Interventional Sciences, University College London, Royal Free Campus, London, UK.
Timothy R ArnettDepartment of Cell and & Developmental Biology, University College London, London, UK.
Stefano FedeleEastman Dental Institute, University College London, London, UK.
Umber CheemaUCL Centre of 3D Models Health and Disease, Division of Surgery and Interventional Sciences, University College London, Charles Bell House, London, UK. u.cheema@ucl.ac.uk.
University College London · GBKagoshima University · JPEastman Dental Hospital · GBThe Royal Free Hospital · GBUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ameloblastoma is a benign, epithelial cancer of the jawbone, which causes bone resorption and disfigurement to patients affected. The interaction of ameloblastoma with its tumour stroma drives invasion and progression. We used stiff collagen matrices to engineer active bone forming stroma, to probe the interaction of ameloblastoma with its native tumour bone microenvironment. This bone-stroma was assessed by nano-CT, transmission electron microscopy (TEM), Raman spectroscopy and gene analysis. Furthermore, we investigated gene correlation between bone forming 3D bone stroma and ameloblastoma introduced 3D bone stroma. Ameloblastoma cells increased expression of MMP-2 and -9 and RANK temporally in 3D compared to 2D. Our 3D biomimetic model formed bone nodules of an average surface area of 0.1 mm

Indexed as

OsteogenesisStromal CellsAmeloblastomaAnimalsBone ResorptionCore Binding Factor Alpha 1 SubunitGene ExpressionHumansJaw NeoplasmsMatrix Metalloproteinase 2Neoplasm InvasivenessOsteoblastsRANK LigandRatsTissue EngineeringTumor Cells, CulturedCore Binding Factor Alpha 1 SubunitMatrix Metalloproteinase 2RANK LigandRunx2 protein, rat

Identifiers

PMID34916549
PMCPMC8677805
OpenAlexW4200588925

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.